Luye Pharma Group Limited — Director's Dealing 2024

Dec 18, 2024

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Pharma
绿叶制药

LUYE PHARMA GROUP LTD.
绿叶制药集团有限公司
(Incorporated in Bermuda with limited liability)
(Stock Code: 02186)

VOLUNTARY ANNOUNCEMENT

INCREASE IN SHAREHOLDING IN THE COMPANY
BY CONTROLLING SHAREHOLDER

The board of directors of LUYE PHARMA GROUP LTD. (the "Company") announces that it was informed by Mr. Liu Dian Bo ("Mr. Liu"), being an executive director and the executive chairman of the Company, that on 18 December 2024, he, through his controlled corporation, LuYe Pharmaceutical Investment Co., Ltd., purchased an aggregate of 2,000,000 ordinary shares ("Shares") of the Company at an average price of approximately HK$2.2299 per Share on the market. After the purchase and as at the date of this announcement, Mr. Liu is interested in 1,261,196,703 Shares, representing approximately $33.53\%$ of the total issued share capital of the Company.

As advised by Mr. Liu, he is confident about the growth, development and future prospects of the Company and may further increase his interests in the Shares as and when appropriate and subject to compliance with the applicable laws and regulations.

The shareholders and potential investors of the Company are reminded to exercise caution when dealing in the securities of the Company.

By Order of the Board
LUYE PHARMA GROUP LTD.
Liu Dian Bo
Chairman

Hong Kong, 18 December 2024

As at the date of this announcement, the executive directors of the Company are Mr. LIU Dian Bo, Mr. YANG Rong Bing, Mr. YUAN Hui Xian and Ms. ZHU Yuan Yuan; the non-executive directors of the Company are Mr. SONG Rui Lin and Dr. LYU Dong; and the independent non-executive directors of the Company are Mr. ZHANG Hua Qiao, Professor LO Yuk Lam, Mr. LEUNG Man Kit, Mr. CHOY Sze Chung Jojo and Ms. XIA Lian.